EN IT

Pfizer: the decline slows, but the technicals haven't turned yet

Pfizer technical analysis, week 9 of a sell signal: the week closes nearly flat after two straight declines, with a double bottom and a 6% rebound, while MACD and histogram keep worsening.

Pfizer: the decline slows, but the technicals haven't turned yet
Pfizer, week 9 of a sell signal
Pfizer: the decline slows, but the technicals haven't turned yet
July 03, 2026
Pfizer, week 9 of a sell signal
In Summary
Ninth week of the sell signal on Pfizer, and the week closed nearly flat (+0.1%) after two straight down weeks. Buying volume climbed back to 70%, and a double bottom formed in the 24 area on the daily chart with an intermediate 6% rebound. The short-term technical picture, though, hasn't turned yet: MACD and the histogram remain worse than a month ago.
Ongoing decline ·9th week from start ·US stocks ·T2 ★ See Gold version →
IQS Phase
85
in tension / maturity
Signal Strength
34
decline losing steam
Sizing
REDUCED
Ranking
#6 / 137
US stocks
Trade P&L %
+5.30%
from signal to today
Chart · Weekly — EMA50 · MACD · VWAP
Weekly chart · EMA50 · MACD · VWAP · Source: TradingView
How to read this pageA visual guide to the post, card by card
The full analysis, operating plan and detailed levels on this asset are reserved for clients ★ PLATINUM
restricted Platinum content
Share WhatsApp Telegram Gmail LinkedIn